John J. Fedele

John’s practice spans a wide range of antitrust matters. He represents clients in merger investigations before U.S. and international competition authorities, and provides strategic counsel on commercial arrangements such as distribution agreements, joint ventures, and supply agreements. He also advises on antitrust compliance programs and risk assessments.

John’s experience covers a diverse set of industries, including aerospace and defense, automotive, agriculture, oil and gas, chemicals, finance, healthcare, medical devices, and waste. His ability to navigate complex regulatory landscapes and coordinate multi-jurisdictional teams makes him a trusted advisor for clients facing high-stakes antitrust scrutiny.

• Advised Safran S.A. on its acquisition of Collins Aerospace’s actuation and flight control business, including coordinating global regulatory reviews across multiple jurisdictions.

• Advised Olink Holding AB in its sale to Thermo Fisher Scientific in an all-cash transaction valued at approximately USD 3.1 billion, including coordinating competition filings in multiple jurisdictions investigating the proposed combination. The transaction was a finalist for the Global Competition Review’s 2025 Merger Control Matter of the Year (Europe).

• Advised Sika AG on its approximately USD 6 billion acquisition of MBCC Group.

• Advised Brunswick Corporation on its acquisition of Navico, including leading the competition aspects of the transaction in the US and globally.

• Advised Zen-Noh Grain Corporation on its acquisition of a portfolio of grain origination elevators from Bunge North America, Inc., the review of the transaction by the DOJ Antitrust Division, and the divestiture of certain assets to a DOJ approved buyer following the negotiation of a consent decree with the DOJ.

• Advised the Safran Group on the international and US competition and regulatory aspects of its sale of Morpho Detection to Smiths Detection, a division of Smiths Group. The transaction received significant scrutiny from the Antitrust Division and was a finalist for the Global Competition Review's 2018 Merger Control Matter of the Year (Americas).

• Advised CLARCOR Inc., a major manufacturer of filtration products, on the US antitrust aspects of its USD 4.3 billion sale to Parker Hannifin Corporation.

• Advised Fresenius Medical Care AG & Co. KgaA, one of the largest suppliers of outpatient dialysis services in the United States, in the Federal Trade Commission's investigation of its acquisition of Liberty Dialysis Holdings, Inc. The transaction was valued at approximately USD 2.1 billion and involved over 100 distinct geographic markets.

• Advised Gardner Denver, Inc., a worldwide compressor manufacturer, in its USD 3.9 billion sale to Kohlberg, Kravis Roberts & Co. L.P. (KKR), a global investment firm.

• Advised One Equity Partners on its acquisition, and later sale, of Sonneborn, Inc., including the coordination of premerger notifications in multiple jurisdictions.

• Advised Prestige Brands Holdings, Inc. on its acquisition of seventeen brands from GlaxoSmithKline, including the coordination of premerger notifications in multiple jurisdictions.

• Advised Stericycle, Inc. in the Antitrust Division's investigations of its acquisitions of its largest domestic competitors, Healthcare Waste Solutions and Medserve, Inc.

• Advised Labinal, Inc., a company of the Safran Group, on its acquisition of Harvard Custom Manufacturing, Inc., a manufacturer of electrical wiring systems for commercial and military aerospace applications, and performed all merger-control analyses.

• Who’s Who Legal 2020 to 2024 ranks him as a "Future Leader of Competition," noting his "business acumen, practicality, calmness, responsiveness, skill and knowledge."

• American Bar Association, Antitrust Section - Health Care & Pharmaceuticals Committee, Vice-Chair